Many American adults–nearly 60 million, according to some recent consumer surveys–have difficulty affording their prescription drug medicines even with insurance, putting their health and financial priorities at odds.
Complex generics have the potential to generate significant savings for patients and the health care system. But market dynamics and regulatory complexities are seen as significant hurdles.
Join The Hill for a discussion with leading medical voices, policy experts, and members of Congress to discuss how complex generic medical alternatives can impact and potentially enhance the American healthcare system.
· What policies can be put into place to safely accelerate evaluation and approval timelines? Â
· How could next year’s reauthorization of the Generic Drug User Fee Amendments create opportunities to institute innovative policy changes?
· How is the pandemic’s spotlight on therapeutics and pharmaceutical development timelines likely to influence the thinking behind complex generic approval processes?
